# FDA Inspection 1028107 - Senador Laboratories Private Limited - August 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/senador-laboratories-private-limited/bbdf592a-0231-47c1-a031-bcbd5650ea81
Source feed: FDA_Inspections

> FDA inspection 1028107 of Senador Laboratories Private Limited, August 29, 2017. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028107
- Company Name: Senador Laboratories Private Limited
- Inspection Date: 2017-08-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1305216 - 2025-11-24](https://www.keypedia.com/records/fda_inspections/senador-laboratories-private-limited/bcdf9200-ea91-4965-8935-13c8a06d8408)
- FDA Inspection 1107337 - 2019-09-16
- FDA Inspection 1037438 - 2017-11-24
- FDA Inspection 891441 - 2014-07-25
- [FDA Inspection 790200 - 2012-06-28](https://www.keypedia.com/records/fda_inspections/senador-laboratories-private-limited/b63ad64e-8bfd-4329-81af-2eb8f33b057b)

Company: https://www.keypedia.com/companies/senador-laboratories-private-limited/07781b9f-6d88-4334-96e4-438175fbaf9d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c